• Adaptée à tous les âges et à tous les profils, simple et innovante, la câlinothérapie est la méthode de développement personnel par excellence. Elle maintient en bonne forme physique et psychique et constitue l'outil de réparation le plus puissant que nous connaissions par la libération de l'ocytocine, « l'hormone du bonheur ». Preuves à l'appui, les chercheurs nous montrent la voie en partageant leurs dernières découvertes. Que ce soit en psychologie, en neurologie ou jusque dans notre propre ADN, nous ne pensons plus aujourd'hui comme hier.

    Confrontés à une masse d'informations toujours plus grande, il nous faut sortir de ce vertige pour revenir à l'essentiel. Faire de la place en soi, désencombrer son esprit, deviennent un enjeu pour notre survie. Revenir à l'essentiel est ce qu'il y a de plus difficile à atteindre. Pour cela, il nous faut faire un ménage interne, nous débarrasser de ce qui ne nous sert plus et qui, au contraire, nous empoisonne. Si c'est le souhait exprimé de chacun, une question cependant demeure : oui, mais comment ?

    La réédition de cet ouvrage permettra à tous de faire le point sur le rapport à son enfant intérieur, aux autres, à sa bienveillance. Il propose aussi des exercices pratiques afin de réparer, de la façon la plus efficace qui soit, ses failles et ses manques, freins majeurs à notre harmonie et notre bien-être.

  • Qu'est-ce que la câlinothérapie? Quels sont les bienfaits des câlins sur la santé? Les récentes découvertes montrent que le câlin améliore notre bien-être par la libération de l'hormone du bonheur: l'ocytocine, et entraîne une chute du taux de cortisol, l'hormone du stress.Face à cette demande d'un genre nouveau, les propositions fleurissent: des "free hugs" aux bars à câlins, des animaux à caresser...Tout est prétexte à câliner et se faire câliner.

  • Documenting the latest research in the field of different pathogenic organisms, this book presents the current scenario about promising antimicrobials in the following areas: Part I. Plants as source of antibacterials, Part II. Naturally occurring antifungal natural products, Part III. Antiparasitic natural products, Part IV. Antiviral natural products. Renowned scientists from the globe have been selected as authors to contribute chapters. Use of plants for various ailments is as old as human civilization and continuous efforts are being made to improve medicinal plants or to product their bioactive secondary metabolites in high amounts through various technologies. About 200,000 natural products of plant origin are known and many more are being identified from higher plants and micro-organisms. Some plants based drugs are used since centuries and there is no alternative medicine for many such drugs as cardiac glycosides. Drug discovery from medicinal plants or marine micro-organisms continues to provide an important source of new drug leads. Research on new antibacterials represents a real and timely challenge of this century, particularly for the treatment of infections caused by clinical isolates that show multidrug resistance. The main microorganisms involved in the resistance process have been identified and given the acronym ESKAPE for Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumanii, Pseudomonas aeruginosa and Enterobacteriaceae. Multidrug resistant Mycobacterium tuberculosis including highly drug-resistant strains (XDR-TB) has also emerged as one of the most important clinical challenges of this century. Plants of diverse taxa and marine micro-organisms are rich source of these antimicrobials. An attempt has been made to compile the recent information about natural sources of antibacterials and their sustainable utilization. Increased panic of these pathogens warrants a growing demand for research to undertake the threat of multidrug resistance. The search for new antifungal, antiparasitic and antiviral natural products is far from devoid of interest. According to the WHO report in 2013, malaria still represents some 207 million cases worldwide and more than 3 billion of people are still exposed to this risk. Similarly, about 350 million people are considered at risk of contracting leishmaniasis. The fight against some viruses also requires that the research on natural products continue. For example, even if an antiretroviral with direct action was recently approved in Europe in 2013, its high cost does not allow to offer it to an exposed population in countries where the cost of drugs remains a problem for a large part of the population. These books are useful to researchers and students in microbiology, biotechnology, pharmacology, chemistry and biology as well as medical professionals.

empty